Your browser doesn't support javascript.
loading
Mitochondria are required for pro-ageing features of the senescent phenotype.
Correia-Melo, Clara; Marques, Francisco D M; Anderson, Rhys; Hewitt, Graeme; Hewitt, Rachael; Cole, John; Carroll, Bernadette M; Miwa, Satomi; Birch, Jodie; Merz, Alina; Rushton, Michael D; Charles, Michelle; Jurk, Diana; Tait, Stephen W G; Czapiewski, Rafal; Greaves, Laura; Nelson, Glyn; Bohlooly-Y, Mohammad; Rodriguez-Cuenca, Sergio; Vidal-Puig, Antonio; Mann, Derek; Saretzki, Gabriele; Quarato, Giovanni; Green, Douglas R; Adams, Peter D; von Zglinicki, Thomas; Korolchuk, Viktor I; Passos, João F.
Affiliation
  • Correia-Melo C; Institute for Cell and Molecular Biosciences, Campus for Ageing and Vitality, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, UK GABBA Program, Abel Salazar Biomedical Sciences Institute University of Porto, Porto, Portugal.
  • Marques FD; Institute for Cell and Molecular Biosciences, Campus for Ageing and Vitality, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, UK.
  • Anderson R; Institute for Cell and Molecular Biosciences, Campus for Ageing and Vitality, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, UK.
  • Hewitt G; Institute for Cell and Molecular Biosciences, Campus for Ageing and Vitality, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, UK.
  • Hewitt R; Institute of Cancer Sciences, CR-UK Beatson Institute, University of Glasgow, Glasgow, UK.
  • Cole J; Institute of Cancer Sciences, CR-UK Beatson Institute, University of Glasgow, Glasgow, UK.
  • Carroll BM; Institute for Cell and Molecular Biosciences, Campus for Ageing and Vitality, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, UK.
  • Miwa S; Institute for Cell and Molecular Biosciences, Campus for Ageing and Vitality, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, UK.
  • Birch J; Institute for Cell and Molecular Biosciences, Campus for Ageing and Vitality, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, UK.
  • Merz A; Institute for Cell and Molecular Biosciences, Campus for Ageing and Vitality, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, UK.
  • Rushton MD; Institute for Cell and Molecular Biosciences, Campus for Ageing and Vitality, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, UK.
  • Charles M; Institute for Cell and Molecular Biosciences, Campus for Ageing and Vitality, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, UK.
  • Jurk D; Institute for Cell and Molecular Biosciences, Campus for Ageing and Vitality, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, UK.
  • Tait SW; Institute of Cancer Sciences, CR-UK Beatson Institute, University of Glasgow, Glasgow, UK.
  • Czapiewski R; Institute for Cell and Molecular Biosciences, Campus for Ageing and Vitality, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, UK.
  • Greaves L; Wellcome Trust Centre for Mitochondrial Research, Newcastle University Centre for Brain Ageing and Vitality, Newcastle University, Newcastle upon Tyne, UK.
  • Nelson G; Institute for Cell and Molecular Biosciences, Campus for Ageing and Vitality, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, UK.
  • Bohlooly-Y M; Transgenic RAD, Discovery Sciences, AstraZeneca, Mölndal, Sweden.
  • Rodriguez-Cuenca S; Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
  • Vidal-Puig A; Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
  • Mann D; Faculty of Medical Sciences, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  • Saretzki G; Institute for Cell and Molecular Biosciences, Campus for Ageing and Vitality, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, UK.
  • Quarato G; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Green DR; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Adams PD; Institute of Cancer Sciences, CR-UK Beatson Institute, University of Glasgow, Glasgow, UK.
  • von Zglinicki T; Institute for Cell and Molecular Biosciences, Campus for Ageing and Vitality, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, UK.
  • Korolchuk VI; Institute for Cell and Molecular Biosciences, Campus for Ageing and Vitality, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, UK.
  • Passos JF; Institute for Cell and Molecular Biosciences, Campus for Ageing and Vitality, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, UK joao.passos@ncl.ac.uk.
EMBO J ; 35(7): 724-42, 2016 Apr 01.
Article in En | MEDLINE | ID: mdl-26848154
Cell senescence is an important tumour suppressor mechanism and driver of ageing. Both functions are dependent on the development of the senescent phenotype, which involves an overproduction of pro-inflammatory and pro-oxidant signals. However, the exact mechanisms regulating these phenotypes remain poorly understood. Here, we show the critical role of mitochondria in cellular senescence. In multiple models of senescence, absence of mitochondria reduced a spectrum of senescence effectors and phenotypes while preserving ATP production via enhanced glycolysis. Global transcriptomic analysis by RNA sequencing revealed that a vast number of senescent-associated changes are dependent on mitochondria, particularly the pro-inflammatory phenotype. Mechanistically, we show that the ATM, Akt and mTORC1 phosphorylation cascade integrates signals from the DNA damage response (DDR) towards PGC-1ß-dependent mitochondrial biogenesis, contributing to aROS-mediated activation of the DDR and cell cycle arrest. Finally, we demonstrate that the reduction in mitochondrial content in vivo, by either mTORC1 inhibition or PGC-1ß deletion, prevents senescence in the ageing mouse liver. Our results suggest that mitochondria are a candidate target for interventions to reduce the deleterious impact of senescence in ageing tissues.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aging / Mitochondria Limits: Animals / Humans Language: En Journal: EMBO J Year: 2016 Document type: Article Affiliation country: Portugal Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aging / Mitochondria Limits: Animals / Humans Language: En Journal: EMBO J Year: 2016 Document type: Article Affiliation country: Portugal Country of publication: United kingdom